Y & Y MANAGEMENT LIMITED
Company number 06276667 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Score: A-
Explanation: Y & Y Management Limited exhibits excellent overall financial health, characterized by robust equity, strong assets, and minimal leverage. However, the score is held back from a perfect grade due to a noticeable "circulatory" issue: while the business is generating healthy profits, its cash reserves are shrinking, and capital is increasingly tied up in debtors. This is akin to a patient with a strong heart but restricted blood flow—vitality is present, but liquidity could become a concern if those debtors do not pay up.
Key Vital Signs
1. Net Assets (Skeletal Health): £16.87 Million The company’s net assets grew from £15.18M in 2023 to £16.87M in 2024. This indicates a very strong structural foundation. Like a healthy skeletal system, the business has excellent support and substance, showing steady, year-over-year growth in overall value.
2. Current Ratio (Immune System Strength): ~8.6x Current assets (£19.11M) vastly exceed current liabilities (£2.23M). This means the company has nearly £9 in short-term assets for every £1 of short-term debt. The business is highly resilient to immediate financial shocks and shows no signs of insolvency risk.
3. Cash Reserves (Circulatory Volume): £2.06 Million Cash has dropped significantly from £9.83M in 2022 to £4.3M in 2023, and now £2.06M in 2024. While still a healthy absolute figure, this downward trend is a symptom that requires monitoring. The business is bleeding cash from its immediate reserves, even while reporting strong overall profitability.
4. Other Debtors (Arterial Plaque): £15.7 Million The most glaring vital sign is the massive increase in "Other Debtors," which surged from £10.86M in 2023 to £15.7M in 2024. This single line item now represents over 82% of the company's total assets. This represents money that is owed to the business but has not yet been converted into cash.
5. Profitability (Muscle Growth): ~£1.69 Million The Profit and Loss reserve grew from £15.18M to £16.87M, indicating that the company generated approximately £1.69M in retained profit over the year. The business is successfully generating wealth, though the cash conversion of this profit is currently poor.
Diagnosis
The patient is suffering from a classic case of "Profit-Rich, Cash-Poor" syndrome, compounded by a severe concentration of financial mass in receivables.
While the P&L reserve shows healthy profit generation (muscle growth), the cash position is draining. This discrepancy is almost entirely explained by the ballooning "Other Debtors" figure. In the property management sector, "Other Debtors" often represents inter-company loans, director loans, or client funds held in a fiduciary capacity. The corresponding increase in "Other Creditors" (up from £637k to £1.5M) suggests that a portion of this may be offset by related payables, but the net position still represents a massive chunk of capital tied up outside the business.
Think of this as a patient eating a highly nutritious meal (generating profit), but the digestive system is slow to process the nutrients into usable energy (cash). The body is well-fed on paper, but immediate energy levels are relying on a diminishing store of glycogen (cash reserves). If these "Other Debtors" represent loans to related parties that are not actively being repaid, the company's cash could dry up entirely, forcing it to seek external financing despite being highly profitable on paper.
Recommendations
- Improve Cash Conversion (Cardiovascular Fitness): Implement a strict debt collection strategy. If the £15.7M in "Other Debtors" includes inter-company balances, the parent company or related entities should establish a repayment schedule to flush this capital back into the operating circulatory system of Y & Y Management Limited.
- Investigate "Other Debtors" (Biopsy): Conduct a deep dive into the composition of the £15.7M "Other Debtors". If these are long-term loans to directors or shareholders, they may never convert to trading cash, which artificially inflates the current assets. Ensure these are properly secured and carry a market-rate interest charge.
- Monitor Cash Runway (Vital Signs Monitoring): With cash dropping by over 50% in the last year, map out the operating cash flow requirements. While £2M is currently sufficient given the low level of trade creditors (£178k), any unexpected large expense could leave the company gasping for air.
- Review Creditor Terms (Blood Pressure Regulation): The rise in "Other Creditors" to £1.5M should be investigated. Ensure these liabilities are not accruing punitive interest rates, which could eat into the healthy profit margins the company is generating.